IP 254 (Ranitidine Hydrochloride 300 mg)
Pill with imprint IP 254 is Yellow, Capsule-shape and has been identified as Ranitidine Hydrochloride 300 mg. It is supplied by Amneal Pharmaceuticals.
Ranitidine is used in the treatment of duodenal ulcer; erosive esophagitis; cutaneous mastocytosis; duodenal ulcer prophylaxis; gerd and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for IP 254
Ranitidine Hydrochloride
- Imprint
- IP 254
- Strength
- 300 mg
- Color
- Yellow
- Shape
- Capsule-shape
- Availability
- Rx and/or OTC
- Drug Class
- H2 antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amneal Pharmaceuticals
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 53746-0254 (Discontinued) | Amneal Pharmaceuticals LLC |
| 65162-0254 (Discontinued) | Amneal Pharmaceuticals LLC |
| 42291-0725 (Discontinued) | AvKare, Inc. |
More about ranitidine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (156)
- Patient tips
- Drug images
- Compare alternatives
- Drug class: H2 antagonists
Patient resources
- Drug Information
- Ranitidine Injection
- Ranitidine Tablets and Capsules
- Ranitidine Suspension
- Ranitidine Syrup
- Other brands
- Zantac
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.